🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Syndrome of inappropriate antidiuresis (SIADH) is characterized by an imbal...
Status
Completed
Location
University Hospital Basel
Start Date
2016-09-05
Trial ID
NCT02874807
Treatments Being Tested
The goal of this clinical trial is to learn if Empagliflozin and Semaglutid...
Status
Recruiting
Location
Research Institute of the McGill University Health Centre
Start Date
2025-04
Trial ID
NCT06894784
The goal of this clinical trial is to learn if giving the drug empagliflozi...
Status
Not Yet Recruiting
Location
Rehman Medical Institute
Start Date
2026-09-01
Trial ID
NCT07749014
Treatments Being Tested
The primary objective of the study is to evaluate the effect of empaglifloz...
Status
Completed
Location
Mobile Heart Specialists, PC
Start Date
2018-03-20
Trial ID
NCT03448419
Treatments Being Tested
To examine whether the empagliflozin-induced stimulation of EGP, lipolysis,...
Status
Recruiting
Location
Texas Diabetes Institute/UH
Start Date
2026-05-11
Trial ID
NCT07053319
Empagliflozin may lead to improved vascular and endothelial function in the...
Status
Completed
Location
University of Erlangen-Nuremberg
Start Date
2014-12
Trial ID
NCT02471963
Treatments Being Tested
Acute decompensated heart failure is the fastest growing disease in the wor...
Status
Completed
Location
TREANT Zorggroep
Start Date
2017-12-18
Trial ID
NCT03200860
Treatments Being Tested
The objective of the current study is to investigate the efficacy, safety a...
Status
Completed
Location
1245.33.01014 Boehringer Ingelheim Investigational Site
Start Date
2009-11
Trial ID
NCT01011868
Treatments Being Tested
The metabolic syndrome occurs in overweight or obese people who also have a...
Status
Enrolling By Invitation
Location
Queen Mary Hospital
Start Date
2025-08-13
Trial ID
NCT07065357
Treatments Being Tested
This study is planned to investigate the impact of Empagliflozin on biomark...
Status
Completed
Location
Barmherzige Brüder Eisenstadt
Start Date
2017-05-11
Trial ID
NCT03087773
Treatments Being Tested